California-Based Biotech Company Signs Build-to-Suit Agreement for New Facility at the Philadelphia Navy Yard

California-based Iovance Biotherapeutics, a biotechnology company that has developed specialized cancer treatments using tumor-infiltrating lymphocyte technology, will build a commercial-scale production facility in the Philadelphia Navy Yard that it expects will provide the capacity to handle treatments for several thousand patients annually.